Package 60219-1362-3

Brand: loteprednol etabonate

Generic: loteprednol etabonate
NDC Package

Package Facts

Identity

Package NDC 60219-1362-3
Digits Only 6021913623
Product NDC 60219-1362
Description

1 BOTTLE in 1 CARTON (60219-1362-3) / 15 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2025-05-22
Brand loteprednol etabonate
Generic loteprednol etabonate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "0e87ba50-9918-4733-8ed3-95ce3c772b07", "openfda": {"upc": ["0360219136229", "0360219136236"], "unii": ["YEH1EZ96K6"], "rxcui": ["311382"], "spl_set_id": ["e8b50444-fd49-427e-9c1b-f75cb1b62bb6"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (60219-1362-1)  / 5 mL in 1 BOTTLE", "package_ndc": "60219-1362-1", "marketing_start_date": "20250522"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (60219-1362-2)  / 10 mL in 1 BOTTLE", "package_ndc": "60219-1362-2", "marketing_start_date": "20250522"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (60219-1362-3)  / 15 mL in 1 BOTTLE", "package_ndc": "60219-1362-3", "marketing_start_date": "20250522"}], "brand_name": "LOTEPREDNOL ETABONATE", "product_id": "60219-1362_0e87ba50-9918-4733-8ed3-95ce3c772b07", "dosage_form": "SUSPENSION/ DROPS", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "60219-1362", "generic_name": "loteprednol etabonate", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LOTEPREDNOL ETABONATE", "active_ingredients": [{"name": "LOTEPREDNOL ETABONATE", "strength": "5 mg/mL"}], "application_number": "ANDA217484", "marketing_category": "ANDA", "marketing_start_date": "20250522", "listing_expiration_date": "20261231"}